untranslated regions, suggesting that the expression of cathepsin €3 may be regulated, in part at least, at the level of mRNA processing [SJ. Cathepsin R is synthesized as a preproenzyme [lo] in the rough endoplasmic reticulum, and then undergoes several post-translational modifications before being packed into lysosomal vesicles [ 1 11 . Activation of the proenzyme, procathepsin €3, is assumed to take place within lysosomes either by active cathepsin €3 itself, or by the action of a cathepsin D-like aspartic proteinase [l2] . Although cathepsin R does not appear to be stable in vitro at pH values above 6.5, precise kinetic measurements have shown that the enzyme is, in fact, most active at p H = 8.0 [ 131. Instability seems, therefore, to be mainly due to rapid autolysis of the enzyme at pH values above 6.5 [ 141.
Secretion of active cathepsin B by tumour tissues
More than 20 years ago, active lysosomal cathepsin H was reported to be released into the interstitial fluid of growing, solid tumours in the mouse. In addition, at pH 7.1, this enzyme was shown to be able to detach cells grown in vitro in a very similar way to trypsin [ 151. This led to the hypothesis that extracellularly released cathepsin R might contribute directly to the invasiveness of tumour cells and to the destruction of adjacent host tissue. Other investigators have reported that secretion of active cathepsin R from human breast carcinoma tissue explants was much higher than from fibroadenomas or normal breast tissue [ 161. Subsequent characterization of the enzyme activity secreted from these carcinoma explants revealed that the enzyme was similar to human liver cathepsin B. The tumour enzyme, however, had a higher molecular mass and was more stable at pH values 2 7.0 [ 171. In another study, a comparison of the preoperative serum level of cathepsin B activity, with that secreted by the iso-lated human cervical carcinoma cells excised at surgery, showed a clear correlation between the secreted activity levels in vivo and in vitro. Addi [21] , although the molecular basis for these phenomena is not understood. Therefore, special emphasis will be given here to the secretion of cathepsin R by tumour cells.
Our laboratory is mainly interested in the pericellular proteolytic events accompanying tumour invasion.
Accumulation of latent cathepsin B in human cancerous exudates
The bulk of cathepsin R secreted by tumour cells accumulates extracellularly as inactive, or latent, enzyme. Latent cathepsin R was shown to accumulate in ascitic fluid of a patient with ovarian carcinoma, and to be secreted into growth medium by ascites cells taken from the same patient. Active cathepsin H could be generated in vitro upon treatment of this extracellular fluid with the aspartic proteinase pepsin, and activation was accompanied by a shift in molecular mass, from 40 kDa to 33 kDa.
Thus, it was reasonable to assume that the latent form represented a precursor of cathepsin B that had been secreted instead of being targeted to lysosomes [ 221. Latent pepsin-activatable cathepsin B was subsequently also found in pleural effusions from breast cancer patients, and reported to have a molecular mass of about 45 kDa. It was shown to be sensitive to the cysteine proteinase-specific inhibitors E-64 and Z-Phe-Ala-CHzF, only after activation [23] . W e decided to purify this enzyme from the ascitic fluid of a patient with advanced ovarian carcinoma. In contrast to the purification of the pepsin-activated enzyme, which closely followed that of lysosomal cathepsin B [24], isolation of latent cathepsin B proved to be a very difficult task. Initial attempts to dialyse the ascitic fluid at pH 7.4 resulted in a complete loss of latent enzyme, and during purification considerable amounts of latent cathepsin R were converted to active enzyme. Therefore, E-64 was added at each step of the purification procedure and, thus, the spontaneous appearance of active enzyme was dramatically decreased. This permitted the isolation of a 45-47 kDa cathepsin B precursor that remained pepsinactivatable [25] . Polyclonal antibodies raised in sheep against reduced and carboxymethylated human liver cathepsin R, strongly cross-reacted with the purified protein on Western blots [25] and gave a reaction of total identity with the purified pepsin-activated enzyme in double immunodiffusion experiments (unpublished work). We concluded that the latent enzyme indeed represented a true proenzyme of cathepsin B.
Secretion of latent cathepsin B and cystatin C in vitro by colon carcinoma cells
Further studies in our laboratory showed that human colon carcinoma cells not only secreted latent cathepsin B into culture media [19] , but also one of its endogenous inhibitors, cystatin C [26]. Cystatin C is a member of the cystatin superfamily, which comprises a group of proteinase inhibitors that form tight and reversible complexes with cysteine proteinases [8, 271. Cystatin C belongs to family 2 of secreted inhibitors and has been reported to be synthesized in many tissues [28] and to be present in most biological fluids [29] . However, neither this inhibitor, nor other secreted cystatins, had been studied with respect to tumour invasion and metastasis. When ten human colon carcinoma cell lines were analysed, they were all found to express the 2.3 and 4.0 kb mRNAs of cathepsin B, and the 0. 
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Abrahamson, unpublished work). In contrast to these biological response modifiers, two agents, phorbol 12-myristate 13-acetate (PMA) and the acidotropic agent ammonium chloride, significantly increased secretion of latent cathepsin B without affecting secretion of the inhibitor in vitro. The protein synthesis inhibitor, cycloheximide, drastically inhibited secretion of both the enzyme and the inhibitor (D. Keppler and M. Abrahamson, unpublished work). Our results clearly show that latent cathepsin H is a true proenzyme rather than a cathepsin H-cystatin C complex. They do not exclude the possibility that latent cathepsin B may interact with cystatin C; this aspect clearly needs more detailed biochemical analysis using purified proteins. The cathepsin B and cystatin C genes have both recently been reported to be under the control of housekeeping type promoters [9, 281, which may explain the lack of modulation of their expression by cytokines. On the other hand, PMA is a well-known agent that activates numerous transcription factors and alters the genetic programme of the cells [31] .
To elicit a response similar to that obtained with PMA, a synergistic action of different endogenous cytokines may be necessary.
Accumulation of latent cathepsin B and cystatin C in experimental mouse ascites
Since colon carcinoma cells secrete latent cathepsin H and cystatin C in vitro, we wondered whether they would do so in vivo, after intraperitoneal injection into nude mice [32] . For this, five congenitally athymic female nude mice, maintained in barrier isolators, were used for each cell line. Cystatin C was quantified using a sandwich enzyme immunoassay described previously [ 331. A modified version of this assay was elaborated to specifically quantify human cystatin C in mouse samples. For this, the monoclonal antibody was biotinylated and subsequently detected using peroxidaselabelled avidin.
From reported the presence of only trace amounts of active enzyme in human serum [ 3 ] . In the murine system, when production of ascites was induced by injection of mouse monoclonal hybridomas, latent mouse cathepsin B was also found to accumulate intraperitoneally. Thus, with the tools presently available, the precise cellular origin of cathepsin B could not be established. When cystatin C was analysed in the same biological fluids (Figure lb) , its cellular origin could be defined unambiguously after modification of the enzyme immunoassay to abolish interference by mouse immunoglobulins present in the samples. As a consequence, no cystatin C was measured in mouse serum and ascitic fluids induced by mouse cells (Figure lb) . Colon carcinoma cells secreted human cystatin C in vivo at levels comparable to those in vitro [26] . When 1 ml of C o l l 5 cell-induced mouse ascitic fluid was passed over a size-exclusion chromatography Sephacryl S-200 HR column (2.6 c m x 9 5 cm), equilibrated in 50 mM sodium phosphate buffer, pH 6.5, containing 150 mM NaCl and 0.1% (v/v) Triton X-100, a single peak containing latent, pepsin-activatable cathepsin B was recovered (Figure 2a) . The latent enzyme from this fluid eluted closely behind ovalbumin (43 kDa) that was used for the calibration of the column. It did not elute at the same position as active bovine cathepsin B (28 kDa). As an additional control, a preformed complex of bovine cathepsin B and recombinant human cystatin C was run under the same conditions (Figure 26 ). Active bovine cathepsin B dissociated from this complex during chromatography and was eluted at the same position as free cathepsin €3. Recombinant cystatin C was eluted in two peaks: one minor peak corresponding to dimerized cystatin C and one large peak corresponding to monomeric cystatin C. Active bovine cathepsin B, after preincubation with mouse ascitic fluid (induced by Col15 cells) for 30 min at 37"C, eluted in two peaks: one main peak (72%) represented free cathepsin B, the other peak (28%) eluting close to 
Activation of latent cathepsin B by neutrophil elastase
The role of tumour cell-secreted latent cathepsin R has remained very speculative since the only proteinases known to be capable of activating this enzyme, pepsin and cathepsin D, require very acidic conditions for activity. Recently, however, it has been shown that treatment of sputum (from patients with bronchiectasis) with polymorphonuclear neutrophil (PMN) elastase generated a 5-6-fold increase in cathepsin H activity. This increase was accompanied by a shift of a 40 kDa molecular mass cathepsin B precursor into a 37 kDa component [34] . Cystatin C was also present in the sputum, and it has been shown that PMN elastase catalytically inactivates cystatin C with respect to inhibition of cathepsin €3 [ 3 5 ] . In a complex biologielastase acts directly on the precursor, or indirectly via inactivation of cystatin C, to release cathepsin H activity. We therefore decided to separate latent cathepsin H from cystatin C, present in a 100-fold concentrated colon carcinoma cell-conditioned medium, by the use of the same gel-permeation column as used above (Figure 2 ). Colo205 medium was chosen because it contained high levels of latent cathepsin B but no detectable cathepsin H or I, [19] . Activation by human PMN elastase was then studied on the concentrated pool of latent cathepsin [7] ; collagenases, specifically the type IV collagenases and stromelysins, represent the metal-dependent proteases [S]; finally, urokinase and plasminogen represent the serine proteases [9] . Each of these enzymes is over-expressed or inappropriately expressed in breast cancer, but none has been fully proven to actually mediate degradation of basement membrane or stromal matrix in breast cancer metastases. The most extensive work has been on aspartyl and metal-dependent proteases; thus they have been primary subjects of our work. 
